This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Sep;62(9):1234-41.

doi: 10.1136/gutjnl-2012-302826. Epub 2013 May 5.

Beyond scoring: a modern interpretation of disease progression in chronic liver disease

Matteo Rosselli¹, Jane MacNaughtan, Rajiv Jalan, Massimo Pinzani

Affiliations

PMID: 23645629
DOI: 10.1136/gutjnl-2012-302826

Beyond scoring: a modern interpretation of disease progression in chronic liver disease

Matteo Rosselli et al. Gut. 2013 Sep.

. 2013 Sep;62(9):1234-41.

doi: 10.1136/gutjnl-2012-302826. Epub 2013 May 5.

Authors

Matteo Rosselli¹, Jane MacNaughtan, Rajiv Jalan, Massimo Pinzani

Affiliation

¹ Division of Medicine, University College London, UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK.

PMID: 23645629
DOI: 10.1136/gutjnl-2012-302826

No abstract available

Keywords: CHRONIC LIVER DISEASE; CIRRHOSIS; FIBROSIS; PORTAL HYPERTENSION.

PubMed Disclaimer

Comment in

Beyond scoring: a modern histological assessment of chronic hepatitis should include tissue angiogenesis.
Guido M, Pizzi M, Sacerdoti D, Giacomelli L, Rugge M, Bolognesi M. Guido M, et al. Gut. 2014 Aug;63(8):1366-7. doi: 10.1136/gutjnl-2013-306658. Epub 2014 Jan 20. Gut. 2014. PMID: 24444767 No abstract available.

Similar articles

Cirrhosis histology and Laennec staging system correlate with high portal pressure.
Rastogi A, Maiwall R, Bihari C, Ahuja A, Kumar A, Singh T, Wani ZA, Sarin SK. Rastogi A, et al. Histopathology. 2013 Apr;62(5):731-41. doi: 10.1111/his.12070. Epub 2013 Mar 7. Histopathology. 2013. PMID: 23470026
Fibrosis in chronic liver disease.
Popper H, Kent G. Popper H, et al. Clin Gastroenterol. 1975 May;4(2):315-32. Clin Gastroenterol. 1975. PMID: 1092488 Review. No abstract available.
Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE. Tacke F, et al. Liver Int. 2011 Jul;31(6):840-9. doi: 10.1111/j.1478-3231.2011.02504.x. Epub 2011 Mar 10. Liver Int. 2011. PMID: 21645215
Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
Suárez-Cuenca JA, Chagoya de Sánchez V, Aranda-Fraustro A, Sánchez-Sevilla L, Martínez-Pérez L, Hernández-Muñoz R. Suárez-Cuenca JA, et al. Exp Biol Med (Maywood). 2008 Jul;233(7):827-39. doi: 10.3181/0709-RM-247. Epub 2008 Apr 29. Exp Biol Med (Maywood). 2008. PMID: 18445764
Pathologic aspects of cirrhosis. A review.
Popper H. Popper H. Am J Pathol. 1977 Apr;87(1):228-64. Am J Pathol. 1977. PMID: 322505 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?
Tagliaferro M, Marino M, Basile V, Pocino K, Rapaccini GL, Ciasca G, Basile U, Carnazzo V. Tagliaferro M, et al. J Pers Med. 2024 Jul 29;14(8):798. doi: 10.3390/jpm14080798. J Pers Med. 2024. PMID: 39201990 Free PMC article. Review.
Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics.
Singh S, Sharma N, Shukla S, Behl T, Gupta S, Anwer MK, Vargas-De-La-Cruz C, Bungau SG, Brisc C. Singh S, et al. Molecules. 2023 Mar 20;28(6):2811. doi: 10.3390/molecules28062811. Molecules. 2023. PMID: 36985782 Free PMC article. Review.
Advances and challenges in cirrhosis and portal hypertension.
Berzigotti A. Berzigotti A. BMC Med. 2017 Nov 10;15(1):200. doi: 10.1186/s12916-017-0966-6. BMC Med. 2017. PMID: 29121925 Free PMC article.
Angiogenesis-related biomarkers in patients with alcoholic liver disease: their association with liver disease complications and outcome.
Kasztelan-Szczerbinska B, Surdacka A, Slomka M, Rolinski J, Celinski K, Cichoz-Lach H, Madro A, Szczerbinski M. Kasztelan-Szczerbinska B, et al. Mediators Inflamm. 2014;2014:673032. doi: 10.1155/2014/673032. Epub 2014 May 18. Mediators Inflamm. 2014. PMID: 24959006 Free PMC article.
Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease.
Margini C, Murgia G, Stirnimann G, De Gottardi A, Semmo N, Casu S, Bosch J, Dufour JF, Berzigotti A. Margini C, et al. Hepatol Commun. 2018 Jul 24;2(8):929-940. doi: 10.1002/hep4.1201. eCollection 2018 Aug. Hepatol Commun. 2018. PMID: 30094404 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information